Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Applied Materials -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (62466)	3/28/2002 3:47:37 PM
From: advocatedevil	Read Replies (2) \| Respond to of 70976

Always nice to book a big win! Congrats Sam! AdvocateDevil

To: Sam Citron who wrote (62466)	3/28/2002 7:21:24 PM
From: Jacob Snyder	Read Replies (3) \| Respond to of 70976

I"m rotating money from AMAT into WPI: WPI is a generic drug company I've followed for years. Recently got slammed, as a couple of drug approvals got rejected by the FDA. I bought a lot (12% of portfolio, on margin) at 26.5 today. That price is a support line, going back for years. The company just said they expect EPS of $1.60-1.70 in 2002. So, that's a PE of 26.5/1.65 = 16. The 5-year PE range is 14-48. LT EPS growth expected to be 20%. The company expected to resubmit the applications with more data, and expects approval this year or next. Hopefully, I get my 55$ AMAT price soon, and sell my next batch. Maybe sell some CSCO also, at 20-22, to get back off margin. Buy low. Sell high. Repeat, repeat, repeat.